PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-18.37%
Negative net income growth while META stands at 10.17%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
11.39%
D&A growth well above META's 11.33%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
61.46%
Some yoy growth while META is negative at -17.82%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
8.74%
SBC growth well above META's 16.57%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-200.00%
Both reduce yoy usage, with META at -271.20%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-273.32%
Both yoy AR lines negative, with META at -147.72%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
162.84%
AP growth well above META's 144.49%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-100.00%
Negative yoy usage while META is 93.48%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
7.55%
Lower 'other non-cash' growth vs. META's 175.76%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-23.24%
Negative yoy CFO while META is 6.39%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-30.52%
Both yoy lines negative, with META at -27.80%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
96.18%
Acquisition growth of 96.18% while META is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-17.31%
Both yoy lines negative, with META at -95.19%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
2.89%
Below 50% of META's 198.35%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
-442.00%
Both yoy lines negative, with META at -645.56%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-51.56%
Both yoy lines negative, with META at -29.73%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
200.00%
Repurchase growth above 1.5x META's 20.28%. David Dodd would see a strong per-share advantage if the share price is reasonably valued.